Openbookopenbook
Equity
BioNeutra Global Corporation(BGACF)
USD --+0.00%
Reward32Low
Risk68Medium-High
📊75%Data
Thin -6% profit margin · Revenue growing 20% YoY
BGACF
+0.0 · +0.00%
USD · PINK
BioNeutra Global Corporation | Consumer Defensive
Capital Destroyer
Market Cap:260113
ℹ️
Reward Rating
32
Low
Bottom 1% (model universe)
75% data coverage
ℹ️
Risk Rating
68
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on BGACF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is BioNeutra Global Corporation?

BioNeutra Global Corporation engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products with a focus on oligosaccharides.

BGACF · Verdict

Limited reward · elevated risk

BGACF has limited near-term tailwinds — growth and balance sheet weigh on the model output.

Based on 88% data coverage

BGACF · Verdict

What’s working & what to watch

Watchouts 4

  • Growth15/100

    Rev -22.1% CAGR · earnings -17.2%

  • Balance sheet16/100

    Current ratio 0.47

  • Profitability21/100

    -19% net margin · -255% ROE

  • Cash flow40/100

    6% free-cash-flow margin

Model-based scoring. For information only — not financial advice.

What is BioNeutra Global Corporation?

BioNeutra Global Corporation engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products with a focus on oligosaccharides. The company offers isomalt oligosaccharide ingredients under the VitaFiber brand for human digestive health. The company is listed on the PINK in USA, operating in the Consumer Defensive sector, with a market capitalisation of 260.11K.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Low (32)

The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorConsumer Defensive
Market Cap260.11K
P/E RatioN/A
Dividend YieldN/A
52 Week High0.067
52 Week Low0.0056
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding46M
No. of EmployeesN/A
IndustryPackaged Foods
ExchangePINK
Beta0.991
CurrencyUSD · Reports in CAD
Websitewww.bioneutra.ca
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.